The global therapeutic respiratory devices market size was valued at USD 10.3 billion in 2021 and is expected to expand at a CAGR of 6.8% from 2022 to 2030. Growing geriatric population base, rising prevalence of respiratory diseases, and rapid technological advancements are the factors accelerating market growth. Furthermore, rising adoption of therapeutic respiratory devices such as nebulizers, humidifiers, and oxygen concentrators are expected to fuel the growth of the market. The increasing prevalence of respiratory diseases such as sleep apnea, Chronic Obstructive Pulmonary disorder is expected to drive the growth of the market. According to the WHO estimates, 3.2 million people died from moderate to severe COPD globally in 2019. Moreover, as per the WHO estimates, COPD is predicted to be the third leading cause of death worldwide.
The rising need for emergency treatment for protracted treatment and prolonged illnesses associated with lung diseases in children as well as adults is expected to drive the growth of the market. According to a survey conducted by the National Library of Medicine, in 2020, an estimated 2,600 thousand people in France were suffering from chronic obstructive pulmonary disease and around 5,500 thousand people were suffering from tuberculosis in 2020.
Respiratory therapeutic devices are more preferred by physicians and patients for the treatment of respiratory disorders as these devices provide medical intervention in acute as well as chronic patient care. According to American Lung Association, there were approximately 9.0 million adults aged over 18 reported to have COPD in the U.S. in 2018 and 2.0 million adults were suffering from emphysema in 2018 in the U.S. Moreover, according to WHO estimates, potentially fatal respiratory diseases, including COPD, tuberculosis, and lung cancer will account for about one in five deaths worldwide by 2030.
The growing prevalence of sleep apnea is also the most significant growth driver of this market. According to the statistics published by the National Sleep Foundation, around 70.0 million Americans were affected by chronic sleep disorders in 2016. Moreover, the prevalence of obstructive sleep apnea was calculated at 12 million in the U.S. with a diagnosis rate of approximately one in 22. The prevalence of this disease is expected to constantly rise during the forecast period, owing to the growing prevalence of cardiovascular diseases, hypertension, and obesity. Such factors are anticipated to drive the growth of the market.
The increasing cases of respiratory diseases globally are one of the major factors driving the market for therapeutic respiratory devices. According to the European Academy of Allergy and Clinical Immunology (EAACI) Global Atlas of Asthma 2021, more than 350 million patients around the world are suffering from asthma. The aging population and rising urbanization along with environmental and lifestyle changes trigger respiratory diseases.
The COVID-19 outbreak caused due to SARS-CoV-2, already affected millions of people globally as of November 2021. The contagious coronavirus is also having an economic impact and implications on most of the sectors including the medical device industry. Furthermore, there is a rising trend of using e-cigarettes in early adolescents and middle-aged people. The increasing number of smokers and smoking-related respiratory disorders are becoming more common. Thus, increasing cases of different types of respiratory diseases and technological advancements in therapeutic devices fuels the market share.
The positive airway pressure devices segment dominated the market and accounted for a revenue share of more than 58.0% in 2021 and is anticipated to register the fastest growth in the forecast period. This can be attributed to increasing incidences of obstructive sleep apnea that are responsible for the growth of this segment. This is attributed to lifestyle-associated factors such as obesity, alcohol consumption, smoking, and conditions such as craniofacial abnormalities. According to the National Library of Medicine, in 2020, 26% of the total population in the U.S. is reported to have obstructive sleep apnea syndrome. Increasing use of these devices by the geriatric patient base is also responsible for the growth of the market.
The HEPA filter technology segment dominated the market in 2021 and accounted for a revenue share of more than 30.0%. High efficiency particulate air filters are employed for particle removal and retention in different therapeutic respiratory devices. As per the CDC guidelines, the therapeutic devices must be equipped with HEPA filtration technology for air filtration. The prevalence of respiratory diseases and their transmission are among the factors that drive the demand for HEPA filter technology. As per the U.S. States Department of Energy (DOE), HEPA filters remove 99.97% of all particles that are greater than 0.3 microns. The technological advancements in the segment are expected to produce a positive impact on the market in the next seven years. These advancements include washable HEPA filters and HEPA 4 technology, which has the Minimum Efficiency Reporting Value (MERV) rating of the filter. It is used to rate the ability of air filters to remove particulate matter from the air.
The humidifier filters segment is anticipated to register the fastest CAGR of 13.0% during the forecast period due to their rising demand for various therapeutic applications. The rising demand for humidifiers in hospitals, schools, homes, and healthcare entities is expected to boost the growth of the humidifier filters segment as filters are needed to prevent the growth of mold, mildew, fungi, and bacteria in the circulating air. Moreover, the increased prevalence of airborne infections such as tuberculosis leads to a rise in demand for filters in humidifiers, thus affecting the segment growth positively.
The ventilator filter segment is also expected to witness significant growth over the projected period, as it plays a vital role in protecting the safety of patients on mechanical ventilation and reducing the risk of cross-contamination. Furthermore, high demand during the COVID-19 pandemic also contributed to its market size in 2021. Some of the players in this segment include Medtronic and Omnia Health, among others.
North America dominated the market and accounted for a revenue share of 51.8% in 2021 owing to the presence of a large geriatric population base and the rising prevalence of chronic respiratory diseases. Furthermore, the major share of the market in North America is due to the availability of reimbursement in U.S. healthcare centers accounts, increasing healthcare awareness, improvement in healthcare infrastructure, increased number of outpatient surgeries, and economic growth favored by broadening insurance coverage.
The government health plans such as Medicaid and Medicare aided by CMS also drive the growth of the therapeutic respiratory devices market in this region. These health plans cover respiratory therapy using respiratory devices such as Continuous Positive Airway Pressure devices for the treatment of COPD and Obstructive Sleep Apnea (OSA). The increasing number of hospitals in North America and rising government funding to the hospitals is accelerating market growth. According to an article published by American Hospital Association, number of hospitals has raised from 6,146 in 2018 to 6,210 in 2019 in the U.S. Technologically advanced devices are being used extensively in hospitals to provide better treatment to patients.
In Asia Pacific, the market is expected to exhibit the fastest growth during the forecast period owing to factors such as the rising prevalence of asthma in adults as well as children and technological advancements. According to statistics released by the Global Initiative for Asthma, it is expected that there will be an increase of an additional 100 million persons with asthma by 2025. Moreover, the increasing need for home healthcare institutions is also a high impact rendering driver of this market in this region. Furthermore, rising disposable incomes and lifestyle-associated changes are also responsible for the significant growth rate in this region over the forecast period.
Major key players implement strategies such as mergers, acquisitions, strategic partnerships, product launch or collaboration with local players to expand their market share. For instance, in December 2021, chart industries collaborated with Howden. Their aim was to deliver an advanced hydrogen solution. Some of the prominent players in the therapeutic respiratory devices market include:
General Electric Company
Koninklijke Philips N.V
ICU Medical, Inc.
Market size value in 2022
USD 9.6 billion
Revenue forecast in 2030
USD 16.1 billion
CAGR of 6.8% from 2022 to 2030
Base year for estimation
2017 - 2020
2022 - 2030
Revenue in USD million and CAGR from 2022 to 2030
Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Product type, technology, filter, region
North America; Europe; Asia Pacific; Latin America; MEA
U.S.; Canada; Germany; France; Italy; Spain; Switzerland; Japan; China; India; Brazil; Mexico; South Africa
Key companies profiled
BD; General Electric Company; Chart industries; Koninklijke Philips N.V.; Compumedics Limited.; ICU Medical, Inc.; CAIRE Inc.; Invacare Corporation; Mindray
Free report customization (equivalent up to 8 analysts’ working days) with purchase. Addition or alteration to country, regional, and segment scope.
Pricing and purchase options
Avail customized purchase options to meet your exact research needs. Explore purchase options
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For the purpose of this report, Grand View Research has segmented the global therapeutic respiratory devices market report on the basis of product type, technology, filter, and region:
Product Type Outlook (Revenue, USD Million, 2017 - 2030)
Piston based hand held nebulizer
Fixed Oxygen Concentrators
Portable Oxygen Concentrators
Positive Airway Pressure Devices
Continuous Positive Airway Pressure Devices
Auto-titrating Positive Airway Pressure Devices
Bi-level Positive Airway Pressure Devices
Technology Outlook (Revenue, USD Million, 2017 - 2030)
HEPA Filter Technology
Hollow Fiber Filtration
Filters Outlook (Revenue, USD Million, 2017- 2030)
Permanent cleanable filters
Mineral absorption pads
Positive Airway Pressure Devices Filter
Ultra fine foam inlet filters
Polyester non-woven fiber filters
Acrylic & Polypropylene fiber filters
Oxygen concentrator filters
Micro Disk Filter
Felt Intake Filter
Activated Carbon Filters
Regional Outlook (Revenue, USD Million, 2017 - 2030)
Middle East & Africa
b. The global therapeutic respiratory devices market is expected to grow at a compound annual growth rate of 6.8% from 2022 to 2030 to reach USD 16.1 billion by 2030.
b. North America dominated the therapeutic respiratory devices market with a share of 51.84% in 2021. This is attributable to the presence of a large geriatric population base and the rising prevalence of chronic respiratory diseases.
b. Some key players operating in the therapeutic respiratory devices market include BD, General Electric Company, Chart industries, Koninklijke Philips N.V., Compumedics Limited., ICU Medical, Inc., CAIRE Inc., Invacare Corporation, and Mindray.
b. Key factors that are driving the therapeutic respiratory devices market growth include a growing geriatric population base, rising prevalence of respiratory diseases, and rapid technological advancements
b. The global therapeutic respiratory devices market size was estimated at USD 10.3 billion in 2021 and is expected to reach USD 9.6 billion in 2022.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.
"The quality of research they have done for us has been excellent."
Unusually high demand for mechanical ventilators is resulting in a significant shortage of these devices in key countries affected by the Covid-19 outbreak. The unmet demand for mechanical ventilators is forcing biomedical engineers and scientists to create makeshift ventilators using respiratory devices such as PAP, manual resuscitators, nebulizers, oxygen concentrators, and others. This is acting as a pivotal factor for the growth of the therapeutic respiratory devices market in recent times. We at GVR are trying to quantify the impact of this pandemic on the therapeutic respiratory devices market. Get your copy now to gain deeper insights on the same.